Race and ethnicity in clinical trials

Defining race and ethnicity has always been a challenge to clinical researchers and including subjects from all racial and ethnic backgrounds is difficult. Historically, many studies have excluded subjects who do not speak English or have only one or two language translations available for patient information and consent forms. Subjects from specific racial and ethnic groups, may well have problems accessing and inequalities in healthcare and will have poorer health outcomes in some countries. Rees CA et al (JAMA Pediatr 2022;176:e220142. doi:10.1001/jamapediatrics.2022.0142) have examined how race and ethnicity in paediatric clinical trials, published from 2011 to 2020 compare with the corresponding United States of America (USA) populations when reporting ethnicity and race. They wanted to see if there was equitable representation of participants who are members of racial and ethnic minority groups in clinical trials. Their hope is that this concept will enhance inclusivity in the scientific process and...
Source: Archives of Disease in Childhood - Category: Pediatrics Tags: Miscellanea Source Type: research